最新更新 :
08/05/2024
抗生素   Tigecycline  
注射液
溶液稳定性 混合物稳定性 影响稳定性的因素 兼容性 用药途径 引用文献 PDF
   化学式  

商品名   商品名     

商品名仅供参考, 药品所用的辅料可能依国家或厂商不同有所不同。

Eticina 墨西哥
Grexyl 墨西哥
Linicetil 墨西哥
Mrsacin 土耳其
Tecygen 智利
Tigecid 土耳其
Tigecilina 厄瓜多尔, 智利, 阿根廷
Tigecycline 加拿大
Tigetop 智利
Tizoxim 阿根廷
Tygacil 丹麦, 冰岛, 加拿大, 匈牙利, 卢森堡, 厄瓜多尔, 哥伦比亚, 土耳其, 墨西哥, 奥地利, 委内瑞拉, 希腊, 德国, 意大利, 挪威, 新西蘭, 日本, 智利, 比利时, 沙特阿拉伯, 法国, 波兰, 爱尔兰, 瑞典, 瑞士, 秘鲁, 罗马尼亚, 美国, 芬兰, 英国, 荷兰, 葡萄牙, 西班牙, 阿根廷, 阿联酋, 马来西亚
Zomiprerin 秘鲁
引用文献   注射液   引用文献 : Tigecycline  
种类 出版物
2262 文献 Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3128 实验室 Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
Prostrakan 2013
3254 文献 Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3332 实验室 Tigecycline (Tigacyl®) - Summary of Product characteristics
Pfizer 2012
3531 实验室 Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics
Wockhardt 2014
3644 实验室 Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3674 实验室 Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3827 海报 Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
ASHP Midyear 2015
3828 海报 Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 海报 So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
3887 文献 Robiyanto R, Zaidi S.T.R, . Shastri M.D, Castelino R.L, Wanandy S.T, Jose M.D, . Patel R.P.
Stability of Tigecycline in Different Types of Peritoneal Dialysis Solutions.
Perit Dial Int 2016 ; 36:410-414.
4055 文献 Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145 文献 Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4528 文献 Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61
4801 文献 Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J.
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2024 ;51,1:

  Mentions Légales